Cancer du sein secondaire chez l’homme après traitement pour maladie de Hodgkin. À propos d’un cas et revue de la littérature
| Autor: | Makhlouf R, Mounir Besbes, Khaled Rahal, G. Jerbi, F Ben Ayed, Lotfi Kochbati, M. Maalej, T. Dhiab, Hammouda Boussen, Amor Gamoudi, F. Benna |
|---|---|
| Rok vydání: | 2000 |
| Předmět: |
Gynecology
Chemotherapy medicine.medical_specialty business.industry medicine.medical_treatment Thyroid medicine.disease Vinblastine Lymphoma Surgery Radiation therapy medicine.anatomical_structure Breast cancer Oncology hemic and lymphatic diseases medicine Radiology Nuclear Medicine and imaging business Thyroid cancer Chemoradiotherapy medicine.drug |
| Zdroj: | Cancer/Radiothérapie. 4:465-468 |
| ISSN: | 1278-3218 |
| Popis: | Hodgkin's disease is now curable in more than 50% of cases, due to its chemo- and radio-sensitivity. However, treatment exposes to a risk of secondary cancer varying from 1 to 10% depending on chemoradiotherapy doses and schedules. We report a case of secondary breast cancer associated with a secondary thyroid cancer observed in a 24-year-old man treated when he was 13 years old by vinblastin and radiation for stage IIA, a Hodgkin's disease. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect